Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Systemic lupus erythematosus vaccine - Abraxis BioScience/MedClone

Drug Profile

Systemic lupus erythematosus vaccine - Abraxis BioScience/MedClone

Alternative Names: 3E10 - American Bioscience/MedClone; 3E10 vaccine; Lupus nephritis vaccine - American Bioscience/MedClone; Monoclonal antibody 3E10

Latest Information Update: 28 Aug 2006

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Abraxis BioScience; American BioScience; MedClone
  • Developer American BioScience; MedClone
  • Class Monoclonal antibodies; Vaccines
  • Mechanism of Action Immunostimulants; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Lupus nephritis; Systemic lupus erythematosus

Most Recent Events

  • 28 Aug 2006 Discontinued - Phase-I for Lupus nephritis in USA (Intradermal)
  • 28 Aug 2006 Discontinued - Phase-I for Systemic lupus erythematosus in USA (Intradermal)
  • 20 Oct 2004 No development reported - Phase-I for Lupus nephritis in USA (Intradermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top